SCHEMBL17844245

SCHEMBL17844245

O=c1c(NCCCCc2ccccc2)c(-c2ccccc2)sn1CC1CCCO1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.42
CYP3A4 P08684 4/20 0.42
CYP2C9 P11712 4/20 0.42
CYP2C8 P10632 1/20 0.42
ADORA2B P29275 1/20 0.42
KDM4E B2RXH2 2/20 0.41
TSHR P16473 2/20 0.41
CTSD P07339 5/20 0.40
ALDH1A1 P00352 4/20 0.40
LMNA P02545 3/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 4/20 0.40
CYP2C19 P33261 4/20 0.40
KMT2A Q03164 3/20 0.40
USP2 O75604 2/20 0.40
CYP2D6 P10635 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5184329 0.79 TYMP (0.42) KMT2AMGLLMEN1
SCHEMBL17844216 0.77 EPHX1 (0.40) KDM4EKMT2AMEN1
SCHEMBL1998329 0.73 ALDH1A1 (0.46) CYP1A2CYP3A4CYP2C9CYP2C8ADORA2B
SCHEMBL17844195 0.72 ASPH (0.41) KDM4EALDH1A1KMT2AHPGDMEN1
SCHEMBL17844110 0.71 MAOA (0.40) KMT2AMEN1
SCHEMBL859158 0.64 RAB9A (0.52) LMNARAB9ASMN1; SMN2KMT2AMGLL
SCHEMBL15212608 0.64 GSK3B (0.59) CYP1A2CYP3A4CYP2C9CYP2C8ADORA2B
SCHEMBL17844229 0.62 MEN1 (0.48) KDM4EALDH1A1LMNARAB9ASMN1; SMN2
SCHEMBL5185885 0.62 LMNA (0.43) CYP1A2CYP3A4KDM4EALDH1A1LMNA
SCHEMBL5186011 0.61 ALDH1A1 (0.48) ADORA2BALDH1A1LMNASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016100619-A2 TREATMENT AND DIAGNOSIS OF CANCER RGENIX, INC. (US) 2016-06-23 WO disclosed